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Objective: Attrition is a common problem in health behaviour change (HBC)
trials. When the degree of attrition differs between treatment conditions, then
this is called differential attrition and is regarded as a major threat to internal
validity. The primary research question of this study was: how often and to
what degree does differential attrition occur in HBC trials?
Design: A systematic review and meta-analysis of a random selection of HBC
trials (k = 60). We meta-analysed the relative attrition rates using a random-
effects model and examined the relationship between the relative attrition rates
and the potential moderators: the amount of human contact in delivery and
the intensity of the intervention/control condition, the type of control
condition, and the follow-up intensity and duration.
Main outcome measures: Relative attrition rates.
Results: The average attrition rate was 18% (SD = .15; M = .15) in the inter-
vention and 17% (SD = .13; M = .13) in the control conditions. The estimated
average relative attrition rate was 1.10 (95% CI: 1.01–1.20, p = .02), suggest-
ing an overall higher attrition rate of 10% in the intervention conditions. This
relative attrition rate was not related to any of the potential moderators.
Conclusion: There is indication of a slightly higher amount of attrition on
average in the intervention conditions of HBC trials.
Keywords: differential attrition; bias; RCT; health behaviour change; internal
validity
Attrition or loss to follow-up after randomisation is a common problem in randomised
controlled trials (RCTs) (de Bruin, McCambridge, & Prins, 2015; Dumville, Torgerson, &
Hewitt, 2006; Schulz & Grimes, 2002). It complicates the statistical analyses and can lead
to bias in the ﬁndings (Molenberghs & Kenward, 2007). When the degree of attrition dif-
fers between the intervention and control conditions in an RCT, then this is typically
called ‘differential attrition’. Participants in these conditions are, if random allocation is
undertaken properly, comparable at baseline (e.g. in terms of prognostic factors). There-
fore, differential attrition can be assumed to be a consequence of differences that arose at
some point after randomisation and can be related to perceived efﬁcacy or tolerability of
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the intervention (Stein, Ipser, & Seedat, 2006). It might also be, for example, that partici-
pants who are ‘treated’ in the intervention condition feel a general obligation to complete
follow-up measurements (Wortman, 1978) compared to those on a waiting list.
Differential attrition is usually regarded as a major threat to the internal validity of a
study (i.e. whether the intervention really did cause behaviour change) (Shadish, Cook,
& Campbell, 2002), but insight into the degree of differential attrition occurring in
RCTs is limited. Previous meta-analyses focusing on a single clinical area found no dif-
ferential attrition in trials regarding interventions aimed at self-monitoring of blood glu-
cose in type two diabetes (Heneghan et al., 2007) and the use of serotonin speciﬁc
reuptake inhibitors in the treatment of posttraumatic stress disorder (Lurie & Levine,
2010), but did ﬁnd signiﬁcant differential attrition when comparing atypical and typical
antipsychotic medications (Rabinowitz, Levine, Barkai, & Davidov, 2009). In a conve-
nience sample of 10 trials evaluating interventions for the treatment of musculoskeletal
disorders, all trials showed some level of differential attrition, ranging from 1 to 14%
(Hewitt, Kumaravel, Dumville, & Torgerson, 2010). Our group recently published a
meta-analysis of a random sample of RCTs published in general medical journals, but
we observed no evidence that differential attrition generally occurred (Crutzen,
Viechtbauer, Kotz, & Spigt, 2013).
The current study focuses purely on behavioural/educational trials, which are aimed
at health behaviour change (HBC). In other words, changes in behaviour that are
directly related to improvement in health and/or quality of life. HBC trials are generally
thought to be at higher risk of bias than pharmaceutical/medical trials (Crocetti, Amin,
& Scherer, 2010). This increased risk is due to bias-reducing measures (e.g. blinding)
being more difﬁcult to implement in HBC trials (Boutron et al., 2007). A previous
meta-analysis found differential attrition in HBC trials aimed at HIV-prevention, favour-
ing the control condition, which suggests that attrition per condition may be ‘unique
and different from general participation in research’ (Noguchi, Albarracín, Durantini, &
Glasman, 2007). In other words, these differences in attrition might be the result of per-
ceived differences in treatment administered (e.g. intervention vs. control) that are more
likely to occur if participants cannot be blinded – as is mostly deemed to be the case in
HBC trials (Boutron, Tubach, Giraudeau, & Ravaud, 2004). Within the area of hip and
knee osteoarthritis therapy, for example, non-pharmacological studies (i.e. including
HBC trials) less often described blinding of participants in comparison with pharmaco-
logical studies (26.0% vs. 96.7%) (Boutron, Tubach, Giraudeau, & Ravaud, 2003).
There might also be differences between HBC trials concerning certain behaviours (e.g.
less attrition if the behaviour is related to a more serious health problem) or certain
types of interventions. For example, Internet-delivered interventions are thought to be
more prone to attrition (Kohl, Crutzen, & De Vries, 2013). However, this concerns
differences between trials in absolute attrition rates and not necessarily differential
attrition.
To our knowledge, no study has examined the amount of differential attrition in
HBC trials in general (i.e. not focused on a single clinical area or behaviour). This
makes it impossible to draw general conclusions about the degree of differential attrition
in HBC trials. We therefore conducted the present study to address the following pri-
mary research question: How often and to what degree does differential attrition occur
in HBC trials? The secondary research question was: which factors may be related to
the degree to which differential attrition occurs in such studies?
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Methods
We conducted a systematic review and meta-analysis of a random selection of RCTs
published in 10 major health psychology/behavioural medicine journals over the last
decade (2003–2012). We would like to acknowledge a recently made plea for full dis-
closure to maximise scrutiny, foster accurate replication and facilitate future data synthe-
ses (Crutzen, Peters, & Abraham, 2012; Peters, Abraham, & Crutzen, 2012). Therefore,
the search results, screening list, and the list of included and excluded studies, as well
as data, syntax and output of the analyses are available at www.sciencerep.org/11.
Search strategy
To identify the RCTs, we searched PubMed for articles with the following query: (‘Psy-
chol Health’ [JO] OR ‘Health Psychol’ [JO] OR ‘Br J Health Psychol’ [JO] OR ‘J
Health Psychol’ [JO] OR ‘Health Educ Res’ [JO] OR ‘Health Educ Behav’ [JO] OR
‘Ann Behav Med’ [JO] OR ‘J Behav Med’ [JO] OR ‘Int J Behav Med’ [JO] OR
‘Behav Med’ [JO]) AND (‘Randomised Controlled Trial’ [PT] AND humans [MeSH
Terms] AND English [LA] AND 2003:2012 [DP] AND random* [TIAB]). This resulted
in 624 hits of studies, which received an identiﬁcation number.
Selection of studies
Studies were randomly assigned to one of the investigators, using a screening list con-
taining identiﬁcation numbers, who examined whether they met the inclusion criteria. In
particular, the study had to be the primary publication of an RCT with an identiﬁable
intervention and control/comparison condition. The primary outcome of the trial had to
be behaviour change (and not only changes in determinants of behaviour such as atti-
tude or self-efﬁcacy) or biomedical measures indicating this (e.g. changes in HbA1C
resulting from increased physical activity). Furthermore, the trial had to contain human
participants and one or multiple follow-up measurements whose availability was partici-
pant dependent. For example, a trial in which health care utilisation was automatically
assessed by patient records was excluded because of the limited risk of loss to follow-
up. If in doubt, inclusion of the study was discussed with the rest of the research team
until a unanimous decision was reached. If a study did not meet the inclusion criteria, a
new study was randomly selected based on the screening list. This process was contin-
ued until the desired number of studies was selected (i.e. approximately 10% of the
studies on the screening list). Accordingly, we continued the process until 60 studies
were selected (Figure 1).
Analysis of studies
Each included study was independently scored on the items shown in Table 1 by two
of the four investigators in the research team (the one who initially examined the article
for suitability and one additional randomly chosen investigator). So, each investigator
scored 30 studies. Besides descriptive characteristics, these items concerned study char-
acteristics potentially related to differential attrition (e.g. intensity of treatment per con-
dition, type of control; see Table 1). These items were selected based on a previous
study concerning differential attrition (Crutzen et al., 2013) and their face validity in
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line with the study aim, determined upon by all investigators prior to starting data col-
lection. Concordance between scorers was high (e.g. no difference or just a 1-point dif-
ference on a 10-point scale). Disagreements between the two scorers were resolved by
discussion. The intensity of the intervention condition, the control condition and follow-
up procedure was scored on a scale from 1 (lowest intensity; e.g. only an information
leaﬂet or single questionnaire) to 10 (highest intensity; e.g. long-term diary registration
and high-frequency counselling sessions). Human contact in delivery of the intervention
and control condition was classiﬁed as ‘no/low’, ‘intermediate’ or ‘high’. Human con-
tact was added in this study because of its possible relationship with attrition (David,
Alati, Ware, & Kinner, 2013). The number of participants that remained in the study in
the intervention condition and control condition was determined based on the primary
outcome indicated by the authors. When multiple follow-up measurements were taken,
we recorded the number that remained at the last time point that contributed to the pri-
mary analysis (e.g. at 12 months, for a study with measurements at baseline and at 3, 6,
9, 12 and 24 months post-treatment, where the primary analysis is a repeated-measures
analysis for the data up to month 12). If insufﬁcient information was reported to recon-
struct these counts (e.g. only the total number that remained was given), we contacted
study authors in an attempt to obtain this information. For each study, we therefore
attempted to obtain a 2 × 2 table with the number of participants that were lost to
follow-up and the number that remained in the study in the intervention condition and
control condition.
Statistical analysis
Based on the 2 × 2 tables, we calculated the proportion of participants that were lost to
follow-up after randomisation in the intervention and control condition (pI and pC,
respectively) in each study. The outcome of interest for the meta-analysis was the
Figure 1. Flowchart of study selection.
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relative attrition rate (i.e. pI/pC), where a value >1 indicates a higher attrition rate in the
intervention condition and a value <1 indicates a higher attrition rate in the control con-
dition. As is typically done for rate ratios (Fleiss & Berlin, 2009), the actual analysis
was carried out with the log-transformed relative rates (i.e. log(pI/pC)), as this yields
values that are symmetric around 0 and whose sampling distribution is better approxi-
mated by a normal distribution. Studies with no loss to follow-up in either the interven-
tion or the control condition were handled by adding ½ to each cell in the 2 × 2 table,
which not only makes the computation of the log relative attrition rate possible, but
more generally acts as a bias correction (Higgins & Green, 2008). Studies with no loss
to follow-up in both conditions were excluded from the analysis (Higgins & Green,
2008). The sampling variance of the log-transformed relative rates was estimated with
Var [log(pI/pC)] = (1 − pI)/(nI pI) + (1 − pC)/(nC pC), where nI and nC are the number of
individuals randomised to the intervention and control condition, respectively (Fleiss &
Berlin, 2009).
Table 1. Characteristics of selected studies (N = 60).
Total Intervention Control Test for difference
Human contact in
delivery, % (N)
McNemar’s test
(3, N = 60) =
27.00, p < .001
No/low 23.3 (14) 53.3 (32)
Intermediate 26.7 (16) 31.7 (19)
High 50.0 (30) 15.0 (9)
Intensity (range: 1–10,
N = 59*), M (SD)
4.5 (2.3) 2.4 (1.9) t(58) = 7.62,
p < .001
Type of control
condition, % (N)
Waiting list/nothing 20.0 (12)
Usual care 26.7 (16)
Alternative intervention 51.7 (31)
Placebo/sham 1.7 (1)
Follow-up intensity
(range: 1–10,
N = 60), M (SD)
2.5 (1.0)
Follow-up duration
(in months, N = 60),
M (SD)
8.1 (8.9)
Participants randomised
(N = 57*), median
(25th–75th percentile)
72.0 (40.0–154.5) 66.0 (37.5–135.0)
Participants retained
(N = 54*), median
(25th–75th
percentile)
64.5 (34.8–138.5) 57.5 (32.0–130.5)
Participants lost to
follow-up (N = 53*),
median (25th–75th
percentile)
12.0 (4.0–30.0) 9.0 (4.0–26.0)
Note: M = Mean, SD = Standard deviation.
*Number of studies deviates from N = 60 because of missing data.
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Using a random-effects model with restricted maximum-likelihood (REML) estima-
tion for the amount of heterogeneity, we then meta-analysed the log-transformed relative
attrition rates (Raudenbush, 2009). We report the (back-transformed) estimated average
relative attrition rate and corresponding 95% conﬁdence interval, in addition to the
results from the Q-test for heterogeneity and the I2 statistic. The funnel plot was visu-
ally examined for asymmetry (as a potential indicator of publication bias), by means of
the rank correlation and regression test (Sterne & Egger, 2005), and via the trim and ﬁll
method (Duval & Tweedie, 2000a, 2000b). We present a so-called contour-enhanced
funnel plot, which more clearly indicates suppression of non-signiﬁcant values (Peters,
Sutton, Jones, Abrams, & Rushton, 2008).
Next, meta-regression analyses using mixed-effects models and REML estimation
(Raudenbush, 2009) were carried out to examine the relationship between the (log-
transformed) relative attrition rates and various study characteristics that may be related
to the degree of differential attrition: the amount of human contact in delivery and the
intensity of the intervention/control condition, the type of control condition, and the fol-
low-up intensity and duration. Variables coded separately for each condition (i.e. the
amount of human contact in delivery and the intensity) were included in the model as
the difference between the intervention and control condition (with the amount of
human contact initially coded as 0, 1 or 2 for no/low, intermediate and high amounts in
each condition). Type of control condition was examined as a (dummy-coded) factor
(with ‘waiting list/nothing’ as the reference level). The various variables were examined
univariately, jointly in a single meta-regression model, and via backwards elimination.
We report the regression coefﬁcients from the models with corresponding standard
errors, z-values and p-values. In addition, we report the estimated (average) relative
attrition rates (with 95% conﬁdence intervals) based on the models for each level of
the categorical moderator (type of control condition) and for representative values of
the quantitative moderators. For all models, we also checked the data for outliers and
inﬂuential cases using residuals and various case and deletion diagnostics (Viechtbauer
& Cheung, 2010). All analyses were conducted in R (R Development Core Team,
2010) using the metafor package (Viechtbauer, 2010).
Results
Of the 624 studies that were obtained from the PubMed search, a total of 214 studies
had to be screened to identify 60 eligible studies (28%; Figure 1). Thus, a total of 154
studies were not eligible and excluded: 53 (34%) because there were more than two
comparison conditions, 45 (29%) because they were not (a primary publication of) an
RCT, 30 (19%) because they contained a non-behavioural outcome or intervention, 12
(8%) because follow-up was not participant-dependent, 2 (1%) because they were not a
classic RCT, and 12 (8%) for other reasons.
Thirteen studies (22%) did not provide sufﬁcient information to reconstruct the
number of participants randomised and/or retained within each condition. Contacting
the corresponding authors of these studies resulted in the requested information for six
of these 13 studies (46%). Hence, seven studies (54%) had to be excluded because of
insufﬁcient information about the outcome of interest (Figure 1). In the remaining 53
studies, the attrition rates ranged from 0 to .62 (0–62%) both in the intervention and in
the control conditions. The average attrition rate was .18 (18%; SD = .15; M = .15) in
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the intervention and .17 (17%; SD = .13; M = .13) in the control conditions. As shown
in Figure 2, the distribution of the attrition rates was heavily right-skewed in both
conditions.
In one out of the 53 studies, there was no loss to follow-up in both the intervention
and the control condition. This study was therefore removed from the analysis (a sensi-
tivity analysis including this study led to unchanged conclusions). In the remaining 52
studies, the relative attrition rates ranged from .14 to 4.80, with the distribution centred
visibly at a relative rate of 1 (see Figure 3). However, the distribution was not entirely
balanced. In 30 out of 51 cases (59%), the attrition rate was larger in the intervention
condition (and one study had a relative attrition rate of exactly equal to 1).
In four out of the 52 studies (8%), the relative attrition rate differed signiﬁcantly
from 1 at α = .05 (two-sided), which is quite close to the number of signiﬁcant ﬁndings
one would expect to obtain if the true relative attrition rate was equal to 1 in all of the
studies. However, the average relative attrition rate as estimated based on the random-
effects model was 1.10 (95% CI: 1.01–1.20), which was just signiﬁcantly different from
1 (p = .02) and implies a 10% higher attrition rate on average in the intervention
conditions. The data also suggest the presence of a small (I2 = 29.3%) albeit just non-
signiﬁcant (Q(df = 51) = 66.66, p = .07) amount of heterogeneity.
The funnel plot for the 52 studies included in the analysis is shown in Figure 4.
Neither the regression test (p = .37) nor the rank correlation test (p = .29) indicated
asymmetry in the plot. The trim and ﬁll method suggested three potentially missing
studies on the lower right-hand side of the funnel plot (which are small studies with
higher attrition in the intervention condition), but their imputation did not lead to any
substantially changed results (i.e. an estimated average relative attrition rate of 1.11 with
95% CI: 1.02–1.21).
An examination of the studentised residuals, Cook’s distances and weights sug-
gested the presence of ﬁve potential outliers or overly inﬂuential studies. Removing
those studies as part of a sensitivity analysis yielded an essentially unchanged estimated
average relative attrition rate of 1.11 (95% CI: 1.02–1.22), but a notable reduction in
heterogeneity (I2 = 0%, Q(df = 46) = 36.59, p = .84).
Figure 2. Distribution of the attrition rates in the intervention and control conditions.
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None of the potential moderators examined in the meta-regression analyses was
found to be related to the relative attrition rates (see Table 2 for univariate analysis
results). For the type of control condition, all pairwise comparisons between the four
levels were also not signiﬁcant (all pairwise p > .36). The meta-regression model
including all variables simultaneously (or using backward elimination starting with this
model) did not lead to altered conclusions, suggesting that none of the potential moder-
ators was related to the relative attrition rates in a signiﬁcant manner. Again, removal of
the potential outliers of overly inﬂuential studies identiﬁed earlier did not lead to any
changed conclusions with respect to the moderator analyses.
Figure 3. Distribution of the relative attrition rates.
Figure 4. Contour-enhanced funnel plot of the relative attrition rates (>1 indicates higher attrition
rate in intervention condition). Note: white area: p ≥ .1; light grey area: .05 ≤ p < .1; dark grey
area: .01 ≤ p < .05; area outside funnel: p < .01.
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Discussion
The ﬁndings of this meta-analysis demonstrate a slightly higher amount of attrition in
the intervention conditions of HBC trials than in their control conditions. That is, the
estimated relative attrition rate of 1.10 indicates that on average, the amount of attrition
in the intervention conditions was 10% higher compared to the control conditions.
There was no signiﬁcant heterogeneity, which strengthens our conﬁdence to draw gen-
eral conclusions about the degree of differential attrition in HBC trials. This suggests
that the true relative attrition rate is likely to be a fairly ﬁxed constant (i.e. differences
being mostly the result of sampling error). In a previous meta-analysis of a random
sample of RCTs published in general medical journals, we observed no evidence that
differential attrition generally occurred (Crutzen et al., 2013). The ratio of studies in
which the relative attrition rate differed signiﬁcantly from 1, however, was comparable,
namely 7.3% (7/96) in the previous study and 7.5% (4/53) in the study at hand.
Table 2. Meta-regression analysis results on the relationship between the (log) relative attrition
rate and a number of potential moderators (N = 52).
Estimate
(95% CI)a Coefﬁcient SE z p
Difference in amount of human
contact in delivery
.020 .062 .32 .75
At 0 (minimum value) 1.09 (.98–1.21)
At 1 (3rd quartile value) 1.11 (1.00–1.24)
At 2 (maximum value) 1.14 (.93–1.39)
Difference in intensity of the intervention
and control condition (N = 51*)
.018 .023 .80 .42
At 0 (minimum value) 1.08 (.95–1.22)
At 1 (median value) 1.10 (1.00–1.21)
At 3 (3rd quartile value) 1.14 (1.03–1.26)
At 7 (maximum value) 1.23 (.97–1.56)
Type of control condition
(QM(df = 3) = 1.27, p = .74)
Waiting list/nothing (reference level) 1.05 (.81–1.35)
Usual care 1.07 (.87–1.30) .019 .166 .11 .91
Alternative intervention 1.13 (1.02–1.26) .081 .142 .57 .57
Placebo/sham .86 (.48–1.54) −.198 .326 −.61 .54
Follow-up intensity −.021 .046 −.46 .64
At 1 (minimum value) 1.14 (.98–1.32)
At 2 (median value) 1.11 (1.01–1.22)
At 3 (3rd quartile value) 1.09 (.98–1.21)
At 5 (maximum value) 1.04 (.81–1.34)
Follow-up duration .003 .005 .56 .58
At .75 (minimum value) 1.07 (.95–1.22)
At 6 (median value) 1.09 (.99–1.20)
At 12 (3rd quartile value) 1.11 (1.02–1.21)
At 54 (maximum value) 1.24 (.82–1.87)
aEstimated (average) relative attrition rates based on the meta-regression models (with 95% CIs) for all levels
of the categorical moderator (type of control condition) and for representative values of the quantitative
moderators.
*Number of studies deviates from N = 52 because of missing data regarding the intensity variable in one
study.
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As a post-hoc analysis, we closely inspected the four studies in which the relative
attrition rate differed signiﬁcantly from 1 to identify possible factors related to differential
attrition. In three of these studies, the attrition was higher in the intervention condition.
Two of these studies tested tailored interventions stressing the individual responsibility of
behaviour change (e.g. smoking) by personal goal setting and barrier identiﬁcation or
providing feedback on participants’ use of change processes, while the control condition
only received the outcomes measures (Glasgow et al., 2008; Prochaska et al., 2004).
Participants might feel that they are held responsible for their own behaviour or conse-
quences. If, at the same time, they feel that the intervention is not helping them to change
their behaviour, they might decide not to complete follow-up measurements. This is
related to the speculative explanation provided in the next paragraph. The third study
regarding the effects of a Mediterranean lifestyle intervention conducted an attrition anal-
ysis, but did not ﬁnd any interactions between treatment condition and any of the baseline
characteristics: age, weight, waist-to-hip ratio, age diagnosed with diabetes, years taking
diabetes medications, years diagnosed with diabetes, smoking, type of medication,
income, educational level, living arrangement, ethnicity and co-morbidities (Toobert,
Strycker, Glasgow, Barrera, & Angell, 2005). In the one study in which attrition was
higher in the control condition (Blom et al., 2009), the intensity of the control condition
could not be determined (a common problem, as described by Ayling, Brierley, Johnson,
Heller, & Eiser, 2015), while the intensity of the intervention condition was relatively
high (i.e. a stress management intervention consisting of 20 2-h sessions).
A speculative explanation for the slightly higher amount of attrition in the interven-
tion conditions could be that participants in HBC-trials are not blinded for the treat-
ment. Participants are likely to be aware that they are assigned to the intervention
condition and might therefore have higher expectations in terms of perceived treatment
efﬁcacy. If these expectations are not met, then participants in the intervention condi-
tions might be less likely to complete follow-up measurements in comparison with par-
ticipants in the control conditions who might have lower expectations to begin with
(e.g. because they are on a waiting list). An intuitive way to test this hypothesis would
be to link differential attrition to effect sizes regarding primary outcomes of studies.
This was not possible in the current study, because it would be difﬁcult to get a compa-
rable effect size across all studies. Furthermore, the studies concern completely different
types of interventions aimed at different behaviours. Effect sizes will differ in size sim-
ply because of that. Future work could conduct parallel analyses within particular HBC
domains (e.g. smoking cessation, HIV prevention) to control for this and to explore
moderators of differential attrition within these domains.
Another explanation could be that HBC interventions can be cumbersome and are often
preventive in nature. These interventions might target health risk behaviours that partici-
pants do not perceive as being highly problematic, whereas pharmaceutical/medical trials
are often curative in nature. Therefore, participants in HBC interventions might be more
inclined to stop using the intervention and to refuse follow-up measurements. In other
words, the costs of participating in the intervention study do not outweigh the beneﬁts.
The potential moderators tested in this study were not related to the amount of dif-
ferential attrition. Although these moderators already covered a lot of possible differ-
ences between trials (e.g. intensity of treatment, amount of human contact, follow-up
duration), it might be that there are other variables that contribute to explaining differ-
ential attrition. A possible way for future research to explore such variables would be
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to conduct a case-control study in which HBC trials in which the relative attrition rate
differed signiﬁcantly from 1 are matched with comparable trials in terms of behaviour,
target group and the moderators included in the study at hand. Subsequently, inspection
of these trials in pairs could lead to hypotheses regarding variables that contribute to
explaining differential attrition, which could be tested in future meta-analyses. More-
over, including even more trials (e.g. from a larger set of journals) could provide the
opportunity to investigate moderators that have not yet been explored.
Furthermore, our analyses concerned relationships between trial-levels factors and
differential attrition rather than individual-level factors. As suggested before, future
research could systematically study attrition at the individual level with methods that per-
mit detecting biases that a trial-level analysis of studies cannot detect (Noguchi et al.,
2007). Such studies would require other methods as well as access to individual-level
trial data. We would like to stress, however, that we were ultimately interested in the rel-
ative attrition rate. The link to the potentially resultant bias is typically much more direct
and plausible for differential attrition in comparison with absolute attrition. Speciﬁcally,
if there is differential attrition, then a non-random missingness mechanism that operates
in the same way for both groups (e.g. people who do poorly have an elevated chance of
dropping out, regardless of which condition they are in) will lead to bias.
Another valuable ﬁnding of the study at hand is the average overall attrition of
17–18%. This number can be used as a rule of thumb in sample size calculations of
future HBC trials. It also shows that HBC trials have a higher attrition in comparison
with RCTs published in general medical journals, which had an average overall attrition
of 13% (Crutzen et al., 2013). This is in line with one of the main reasons to
conduct this study, namely that HBC trials are usually at a higher risk of bias than
pharmaceutical/medical trials (Crocetti et al., 2010).
The results of this study are limited to HBC trials published in 10 major health psy-
chology/behavioural medicine journals over the last decade. It is possible that editors
and reviewers at major journals are more likely to notice differential attrition as a threat
to validity and reject such studies for publication. Similarly, authors may well decide
not to submit studies with signiﬁcant differential attrition to major journals, fearing it is
only a waste of time. A strength of the present study, however, is the systematic way in
which trials were randomly sampled and independently scored by two investigators.
This is in fact one of the rare cases where a meta-analysis can be said with conﬁdence
to provide a representative sample of studies because there is a clearly deﬁned popula-
tion of studies from which a random sample of studies was taken. Our population con-
sisted of 624 studies, of which 214 had to be sampled to result in 53 eligible studies. If
we extrapolate this rate, then this would result in (53/214) × 624 = 155 eligible HBC tri-
als in our population. This would imply that we have included approximately 34% (53/
155) of the eligible trials in our meta-analysis. So, our key ﬁnding is likely to persist: a
slightly higher amount of attrition in the intervention conditions of HBC trials.
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